Evofem Biosciences, Inc. - stock earnings
EVFM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 26, 2024, midnight | - / - | - | - / - | - |
EVFM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -2.1 million USD | 4.8 million USD |
| 2023Q3 | 66.0 million USD | 5.1 million USD |
| 2023Q2 | -8.6 million USD | 2.5 million USD |
| 2023Q1 | -8.3 million USD | 181000 USD |
| 2022Q4 | 89.5 million USD | 6.4 million USD |
| 2022Q3 | 89.5 million USD | 6.4 million USD |
| 2022Q2 | -126.0 million USD | 6.0 million USD |
| 2022Q1 | -31.9 million USD | 4.3 million USD |
| 2021Q4 | -51.6 million USD | 3.6 million USD |
| 2021Q3 | -74.1 million USD | 1.7 million USD |
| 2021Q2 | -33.4 million USD | 1.9 million USD |
| 2021Q1 | -46.2 million USD | 1.1 million USD |
| 2020Q4 | -40.6 million USD | 168000 USD |
| 2020Q3 | -29.9 million USD | 278000 USD |
| 2020Q2 | -52.7 million USD | ? USD |
| 2020Q1 | -19.1 million USD | ? USD |
| 2019Q4 | -12.7 million USD | ? USD |
| 2019Q3 | -13.8 million USD | ? USD |
| 2019Q2 | -35.5 million USD | ? USD |
| 2019Q1 | -18.1 million USD | ? USD |
| 2018Q4 | -15.0 million USD | ? USD |
| 2018Q3 | -18.4 million USD | ? USD |
| 2018Q2 | -23.2 million USD | ? USD |
| 2018Q1 | -69.1 million USD | ? USD |
| 2017Q4 | -2.4 million USD | ? USD |
| 2017Q3 | -1.8 million USD | ? USD |
| 2017Q2 | -2.8 million USD | ? USD |
| 2017Q1 | -3.0 million USD | ? USD |
| 2016Q4 | -2.0 million USD | ? USD |
| 2016Q3 | -2.4 million USD | ? USD |
| 2016Q2 | -2.7 million USD | ? USD |
| 2016Q1 | -6.0 million USD | ? USD |
| 2015Q4 | -9.5 million USD | ? USD |
| 2015Q3 | -17.3 million USD | ? USD |
| 2015Q2 | -9.5 million USD | ? USD |
| 2015Q1 | -6.9 million USD | ? USD |
| 2014Q4 | -2.9 million USD | ? USD |
| 2014Q3 | -4.0 million USD | ? USD |
| 2014Q2 | -2.3 million USD | ? USD |
| 2014Q1 | -1.6 million USD | ? USD |
| 2013Q4 | -2.8 million USD | ? USD |
EVFM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 53.0 million USD | 18.2 million USD |
| 2022 | -76.7 million USD | 16.8 million USD |
| 2021 | -205.2 million USD | 8.2 million USD |
| 2020 | -142.3 million USD | 446000 USD |
| 2019 | -80.0 million USD | ? USD |
| 2018 | -125.7 million USD | ? USD |
| 2017 | -10.0 million USD | ? USD |
| 2016 | -13.0 million USD | ? USD |
| 2015 | -43.2 million USD | ? USD |
| 2014 | -10.8 million USD | ? USD |
| 2013 | -15.0 million USD | ? USD |
| 2012 | -7.8 million USD | 100000 USD |
EVFM
Price: $0.01
52 week price:
Earnings Per Share: 38.97 USD
P/E Ratio: -0.02
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 2.6 million
Ebitda: -1.8 millionMarket Capitalization: 769486